Balanced news tone
News Sentiment
NVSN sentiment intelligence
Novartis AG news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
49
Balanced news tone
10 relevant articles
News tone and price action are not far from neutral.
77/100 classification confidence.
directly relevant articles
high-authority source matches
-1.5% over one week, -2.8% over four weeks, trend inactive, and near fair-value range.
Novartis AG stock (CH0012005267): Vanrafia Phase III data highlight kidney drug progress
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
77/100 classification
One-week reaction
-1.5%
Price digesting
Trend fit
Trend inactive
-2.8% over four weeks
Fair value
23.8%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
1
Neutral
8
Negative
1
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
AD HOC NEWS
Direct company coverage
Novartis AG stock (CH0012005267): Vanrafia Phase III data highlight kidney drug progress
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- AD HOC NEWS
CoinCodex
Direct company coverage
Novartis AG Tokenized Stock (NVS) Historical Data
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 15:08
- Source
- CoinCodex
PR Newswire
Direct company coverage
Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Oct 2025 07:00
- Source
- PR Newswire
Reuters
Direct company coverage
Novartis nears deal to acquire Avidity Biosciences for over $70 per share, Bloomberg News reports
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 26 Oct 2025 07:00
- Source
- Reuters
PR Newswire
Direct company coverage
Regulus Therapeutics Enters into Agreement to be Acquired by Novartis AG
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Apr 2025 07:00
- Source
- PR Newswire
Reuters
Direct company coverage
Novartis ups yearly outlook but market focuses on disappointing Pluvicto
- Tone
- Negative 34/100
- Event
- Guidance
- Published
- 29 Oct 2024 07:00
- Source
- Reuters
Reuters
Direct company coverage
Cash-flush Novartis launches new share buyback of up to $15 bln
- Tone
- Positive 62/100
- Event
- Capital return
- Published
- 15 Dec 2021 08:00
- Source
- Reuters
Reuters
Direct company coverage
Roche controlling family won't have to make offer after Novartis deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 05 Nov 2021 07:00
- Source
- Reuters
GuruFocus
Direct company coverage
Novartis AG (NVS) Stock Price, Trades & News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Apr 2019 21:08
- Source
- GuruFocus
BioSpace
Direct company coverage
Novartis AG Consolidates Its IT Biz
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Feb 2015 08:00
- Source
- BioSpace